UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:October 20,
Sorrento Therapeutics (NASDAQ:SRNE)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Sorrento Therapeutics Charts.
Sorrento Therapeutics (NASDAQ:SRNE)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Sorrento Therapeutics Charts.

Sorrento Therapeutics, Inc. News

Form 8-K - Current report
Saturday 4 November 2023 (6 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Saturday 28 October 2023 (6 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 13 September 2023 (8 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 29 August 2023 (8 months ago) • Edgar (US Regulatory)
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Tuesday 8 August 2023 (9 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 1 August 2023 (9 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 13 July 2023 (10 months ago) • Edgar (US Regulatory)
Shanghai Escugen Biotechnology Co., Ltd., a partner of Levena Biopharma, a Sorrento Company, releases positive results from a first-in-human study of ESG401, a TROP2 Antibody Drug Conjugate in patients with locally advanced/metastatic solid tumors at the A
Monday 5 June 2023 (11 months ago) • GlobeNewswire Inc.

More Sorrento Therapeutics, Inc. News Articles